The human brain operates as a network of interconnected modules specialized for tasks that become less specialized as people age—a breakdown associated with memory loss and...
CytomX Therapeutics (NASDAQ: CTMX) drew attention a few days ago after its six-year-old, up-to-$1.68 billion cancer collaboration with Astellas Pharma (Tokyo: 4503) was terminated by the...
Novartis has committed up to $3 billion—two-thirds of that upfront—toward acquiring Pikavation Therapeutics, a subsidiary of Synnovation Therapeutics that specializes in developing PI3Kα inhibitor programs designed...
A new Nature Biotechnology paper describes the process of engineering a lab-grown esophagus that can safely replace a full section of the native organ and restore...
Histopathological data remain one of the most trusted tools in science when doctors or researchers want to understand what’s happening inside a tissue. Today, they have...
Huntington’s disease (HD) is a devastating brain disorder that slowly robs people of movement, memory and personality. It is caused by a toxic, mutant Huntingtin (mHTT)...
The Ohio Life Sciences Association (OLSA) and JobsOhio announced the selection of New Albany International Business Park as the location for the newly named Ohio Life...
Lung metastasis remains one of the turning points in cancer progression, in part because the lung provides a uniquely supportive niche for incoming tumor cells. Among...
Much of the challenge in developing cancer therapies is determining methods to improve the effectiveness of the immune system’s ability to identify and kill cancer cells....
Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a new computational tool, TLPath, that can infer changes occurring at the ends of chromosomes—the telomeres—by...